BCM
OPRX icon

Bridgeway Capital Management’s OptimizeRx OPRX Stock Holding History

Bridgeway Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54,029
Closed -$339K – 1293
2026
Q1 		$339K Sell
54,029
-15,000
-22% -$139K 0.01% 903
2025
Q4 		$846K Buy
69,029
+10,000
+17% +$163K 0.02% 731
2025
Q3 		$1.21M Sell
59,029
-40,000
-40% -$635K 0.03% 669
2025
Q2 		$1.34M Hold
99,029
– – 0.03% 608
2025
Q1 		$858K Sell
99,029
-55,071
-36% -$337K 0.02% 665
2024
Q4 		$749K Hold
154,100
– – 0.02% 727
2024
Q3 		$1.19M Hold
154,100
– – 0.03% 637
2024
Q2 		$1.54M Buy
154,100
+43,100
+39% +$473K 0.04% 577
2024
Q1 		$1.35M Sell
111,000
-13,700
-11% -$199K 0.03% 663
2023
Q4 		$1.78M Buy
124,700
+40,600
+48% +$390K 0.04% 621
2023
Q3 		$654K Buy
+84,100
New +$915K 0.02% 813

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Bridgeway Capital Management's OPRX Position: Q2 2026 in Review

Bridgeway Capital Management sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 54,029 shares — an estimated $339K sold.

Bridgeway Capital Management first reported a position in OPRX in Q3 2023 and held it in 11 quarters. The position peaked at $1.78M in Q4 2023. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Bridgeway Capital Management reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 54,029 OptimizeRx shares in Q2 2026, an estimated $339K.
  • Bridgeway Capital Management first reported a position in OptimizeRx in Q3 2023 and held it in 11 quarters.
  • Bridgeway Capital Management's OptimizeRx position peaked at $1.78M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.